All terms
    Investment & FinanceStartup LifecycleSPAC

    Special Purpose Acquisition Company

    A publicly traded shell company formed to raise capital through an IPO with the sole purpose of acquiring or merging with a private operating company.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

    Definition

    A Special Purpose Acquisition Company (SPAC) is a publicly traded shell company that raises capital in an IPO and then has a defined window (typically 18-24 months) to identify and merge with a private operating company in a 'de-SPAC' transaction. Several MedTech companies (e.g., Butterfly Network, Owlet, 23andMe) went public via SPAC during the 2020-2021 boom. The SEC's January 2024 final rule on SPACs materially raised disclosure and gatekeeper liability standards, dampening the market.
    What the regulation says
    SEC Final Rule on SPACs (January 2024), enhanced disclosure of dilution, conflicts, and projections; clearer underwriter and target liability under Section 11.

    What this means in practice

    Post-2024, SPACs are no longer a faster or cheaper path to public markets for most MedTech companies. Many de-SPAC MedTechs traded poorly post-merger, reshaping investor appetite.

    Examples

    • A publicly traded SPAC, after raising capital, sought to acquire an innovative MedTech startup developing a novel diagnostic platform, aiming to bring it to the public market.
    • Following a period of declining investor interest in SPACs, a private biotechnology company chose to pursue a traditional IPO rather than merge with a blank-check company for its public listing.
    • A MedTech firm considering various pathways to go public evaluated a de-SPAC transaction but ultimately decided against it due to the increased regulatory scrutiny and uncertain market reception.
    Common pitfalls
    • •Treating projections in the de-SPAC proxy as marketing rather than as Section 11 liability exposure.

    Frequently asked questions

    In a traditional IPO, a company files its own registration statement and sells shares directly to public investors, while in a de-SPAC transaction a private operating company merges with an already-public shell company (the SPAC) that had previously raised capital in its own IPO for the stated purpose of finding and merging with a target within a defined window, typically 18 to 24 months. Several MedTech companies used this route during the 2020 to 2021 boom as a perceived faster alternative to a traditional IPO process.
    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Ecosystems (1)

    Latest in MedTech

    Sources

    3 sources

    Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 2Regulator guidance and consensus· 2Tier 4Trade press and expert commentary· 1
    Link health: 3 verified· last checked 2026-06-20
    SEC·2NVCA·1
    1. 1
      SEC, SPAC Final Rule (2024)
      Tier 2 Verified
      SECsec.gov
    2. 2
      SEC Final Rule 33-11265, SPACs, Shell Companies, and Projections
      Tier 2 Verified
      SECsec.gov
    3. 3
      NVCA Model Documents
      Tier 4 Verified
      NVCAnvca.org

    Inline markers like [1] jump to the matching reference above.